COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis—Results of the Prospective MSG-017 Study
CAPA is associated with high mortality, but IPA's contribution is unclear. Single positive tests are insufficient for diagnosing CAPA-IPA. IPA likelihood is best estimated by combining test results (both positive and negative).
Authors
- Thomas F. Patterson (ORCID: https://orcid.org/0000-0002-9513-7127)
- Cornelius J. Clancy (ORCID: https://orcid.org/0000-0003-1505-4119)
- Andrej Spec (ORCID: https://orcid.org/0000-0001-7612-4710)
- M. Hong Nguyen (ORCID: https://orcid.org/0000-0003-2065-3239)
- Sixto M. Leal (ORCID: https://orcid.org/0000-0001-6939-9572)
- Luis Ostrosky‐Zeichner (ORCID: https://orcid.org/0000-0002-4784-7589)
- Gerald McGwin (ORCID: https://orcid.org/0000-0001-9592-1133)
- George R. Thompson (ORCID: https://orcid.org/0000-0001-8518-5750)
- John W. Baddley (ORCID: https://orcid.org/0000-0001-9111-625X)
- Drashti Shah
- Peter G. Pappas (ORCID: https://orcid.org/0000-0003-3643-9931)
- Rachel McMullen
Institutions
- Texas Medical Center (US)
- Johns Hopkins University (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Pittsburgh (US)
- Washington University in St. Louis (US)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
- The University of Texas Health Science Center (US)
- University of California, Davis (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1093/ofid/ofaf331
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Astellas Pharma
- Centers for Disease Control and Prevention